Articles tagged with Parkinsons Disease
Researchers have successfully created dopaminergic neurons directly from the skin of patients with Parkinson's disease, preserving aged characteristics and cellular defects. This breakthrough allows for modeling PD-related neuronal defects in a larger cohort of patients, aiming to identify disease causes and potential therapies.
Researchers developed an in-home wireless device that monitors a patient's movement and gait speed to track Parkinson's disease progression. The device uses machine-learning algorithms to analyze over 200,000 data points collected from 50 participants, showing that it can effectively track the severity of the disease.
A new study reveals that aggregates of the protein alpha-synuclein spread in the brains of people with Parkinson's disease through a cellular waste-ejection process called lysosomal exocytosis. This process can lead to the deaths of neurons and ultimately result in the characteristic symptoms of the disease.
A new study published in PLOS Medicine found that people with hospital-treated infections in early- and mid-life had a higher risk of developing Alzheimer's disease (AD) and Parkinson's disease (PD). The research analyzed data on over 291,000 cases and matched controls to identify the association between infections and neurodegenerativ...
A University of Ottawa research team has made new discoveries on how motor skills are learned and stored in the brain. By studying mice, they found that a specific transcription factor called NPAS4 regulates gene changes in inhibitory neurons, leading to the formation of learning-associated neuron ensembles.
Researchers from Johns Hopkins Medicine and Dana Farber Cancer Institute found that irisin reduces levels of a protein linked to Parkinson's disease and halts movement problems in mice. Irisin also speeds up the transport and degradation of alpha synuclein via fluid-filled sacs called lysosomes in brain cells.
Researchers discovered a gene called nervy that helps fruit flies respond to socio-environmental signals to stop fighting. The study's findings have implications for understanding aggression in humans and potentially treating psychiatric disorders like Parkinson's disease.
Scientists at the Francis Crick Institute discovered how a build-up of harmful protein starts to happen within neurons in Parkinson's disease. The research found that misfolded alpha-synuclein clumps on the surface of mitochondria, causing holes and interfering with energy production.
A study found that inactivating a specific protein complex, PRC2, leads to impaired gene silencing and loss of neurotransmitter production in nerve cells. This is linked to Parkinson's disease-like symptoms and mental health problems.
Researchers at MIT developed an AI model that can detect Parkinson's disease from breathing patterns, using a neural network to assess the presence and severity of the condition. The device is non-invasive and can be used in patients' homes without any bodily contact.
Research reveals that physical activity has a noticeable effect on almost all brain regions, with higher intensity and duration increasing brain volume and cortical thickness. The hippocampus, a key memory center, benefits most from physical activity, which can help counteract age-related loss of brain matter.
Researchers found substantial iron deposits in motor circuits of the brain in individuals with high genetic risk for hereditary hemochromatosis, increasing risk for Parkinson's disease and other movement disorders. Males were more affected than females due to natural processes.
Researchers have created a nanobody that can penetrate tough brain cell coatings and disrupt alpha-synuclein clumps, which contribute to neurodegenerative diseases. The nanobody, PFFNB2, shows promise in preventing disease progression in live mouse brains.
A new study finds that COVID-19 infections may predispose individuals to developing irreversible neurological conditions, such as Alzheimer's and Parkinson's diseases. The research also suggests that the virus can cause long-term neurodegenerative diseases, particularly in the elderly and other vulnerable populations.
University of Iowa researchers confirmed a specific brain region, the subthalamic nucleus, plays a critical role in governing mind-body communication for motor control. The study could advance treatment options for Parkinson's disease, a disorder characterized by declining motor coordination.
A genetic defect in flies leads to motor disorders, similar to those found in humans with Parkinson's disease. The study suggests that Creld, a protein involved in energy production, may play an important role in the development of Parkinson's.
A team of scientists has discovered a key link between the protein αSyn and Parkinson's disease, finding that it interacts with immune responses in neurons. This interaction may play a critical role in the development of the disease, suggesting a potential new approach for treatments by targeting inflammatory pathways.
Researchers at Hebrew University have developed a new method using quantitative MRI to diagnose early-stage Parkinson's disease. This technique reveals biological changes in the brain, enabling early diagnosis and monitoring of treatment efficacy.
A study of almost 21,000 people found that moderate drinking is associated with higher iron levels in the brain and poorer cognitive function. Iron accumulation is a potential mechanism for alcohol-related cognitive decline, which can lead to Alzheimer's and Parkinson's diseases.
Researchers at SFU have developed new chemical biological tools to monitor Parkinson’s disease progression, measuring the activity of lysosomal glucocerebrosidase (GCase) enzyme. This breakthrough could lead to improved diagnostics and treatment, as well as a better understanding of other neurodegenerative diseases linked to GCase.
The article discusses global disparities in Parkinson disease, identifying six key areas for improvement: disease burden, advocacy and awareness, prevention and risk reduction, diagnosis, treatment, and care, caregiver support, and research. These findings aim to inform policy decisions and drive action towards reducing health inequities.
A UBC Okanagan study published in Nature-Scientific Reports found that regular small amounts of psilocybin improved mood, mental health, and psychomotor ability in participants. Microdosing was associated with reduced symptoms of depression, anxiety, and stress, particularly among those over 55.
Researchers discovered that copper accelerates protein aggregation in Parkinson's disease, forming ring-shaped structures that can be used as therapeutic targets. The study provides new clues to the development of the neurodegenerative disease.
A recent study published in Movement Disorders found that a buildup of TDP-43 protein may be responsible for PD-related cell death. This discovery suggests a new cause of the disease and could lead to the development of new treatments.
A new study found that specific gene mutations, such as LRRK2 and PRKN, may prolong survival time in Parkinson's patients, while SNCA and GBA mutations may shorten it. This could lead to more personalized treatment plans for patients with these genetic variants.
Researchers found that COVID-19 positive individuals had a higher risk of developing Alzheimer’s disease, Parkinson’s disease, and ischaemic stroke compared to those who tested negative. The study also revealed increased risks for intracerebral haemorrhage and decreased frequencies for other neurodegenerative illnesses.
Researchers used microcircuit models of basal ganglia and thalamus areas to create multiscale models of Parkinson's patient and healthy control brain. They found that in-silico deep brain stimulation could normalize decreased firing rates in subcortical regions, but also caused differential activity in the motor cortex.
Researchers at Brigham and Women's Hospital have identified LIPE, a lipase that degrades triglycerides, as a promising candidate therapeutic target for Parkinson's disease. Inhibiting LIPE reduced alpha-synuclein inclusions and alleviated neurodegeneration in patient-derived neurons and a C. elegans model of toxicity.
A study led by Brigham and Women's Hospital investigators has revealed that alpha-synuclein plays a dual role in Parkinson's disease, interacting with both vesicles and P-body structures. This new understanding may lead to targeted treatments for the disease, with ongoing genetic studies aiming to identify optimal therapeutic targets.
Researchers at USC Dornsife College of Letters, Arts and Sciences have elucidated the structure of a small protein carrying GABA into neurons using cryogenic electron microscopy. This breakthrough could lead to more effective drugs for conditions such as epilepsy, bipolar disorder, schizophrenia, Parkinson's disease, and autism spectru...
Researchers have identified three distinct brain circuits in the thalamus that contribute to Parkinson's disease symptoms, including motor dysfunction and depression. By manipulating these circuits, they were able to reverse Parkinson's symptoms in mice, suggesting potential new therapeutic targets.
A new study published in eClinicalMedicine found that older men experiencing frequent bad dreams were twice as likely to be diagnosed with Parkinson's disease. The researchers suggest that dream changes could serve as an early warning sign for the condition, which may develop years before characteristic symptoms appear.
Researchers at Johns Hopkins Medicine identified a chemical compound that stops the final events in the pathway linked to brain cell death in Parkinson’s disease. The compound, PAANIB-1, blocks the protein parthanatos without affecting its other critical activities, potentially halting neurodegenerative progression.
Researchers at the University of Warwick have identified a novel cellular process called Golgiphagy that helps regulate the degradation of the Golgi complex in cells. This discovery opens new avenues for understanding the underlying mechanisms of diseases such as cancer, Alzheimer's, and Parkinson's.
Researchers at Kobe University and Hiroshima University have developed a biomarker that can diagnose Parkinson's disease from blood serum samples. The 'P450 inhibition assay' uses 12 different human P450s to detect changes in metabolites, allowing for accurate diagnosis with an accuracy rate of 85-88%. This breakthrough could lead to f...
A new study by the University of Birmingham found that dopamine levels can affect emotion recognition in people with neurological disorders. Those with low baseline dopamine levels improved their ability to recognize emotions after receiving a dopamine boost, while those with higher baseline levels became worse at emotion recognition.
A novel preclinical drug has been developed to inhibit the kinase enzyme Cdk5, which is implicated in neuropsychiatric and neurodegenerative conditions. The drug, 25-106, is brain-permeable and shows promise in altering neurobehavior in mice with anxiety-like behavior.
A Johns Hopkins Medicine study found that a protein called STING responds to clean-up signals in brain cells damaged by Parkinson’s disease by creating a cycle of inflammation that accelerates the disease’s progression. In mice with deactivated STING proteins, there was less microglial activity and brain cell death.
A recent study published in Movement Disorders suggests that COVID-19 may increase the risk of developing Parkinson's disease by making brain cells more susceptible to damage. Researchers found that mice infected with SARS-CoV-2 were more likely to exhibit characteristic features of Parkinson's disease after exposure to a toxin.
Researchers analyzed brain volumes of 37 Parkinson’s patients and 27 controls over 8.8 years, finding accelerated grey matter decline in temporal and occipital lobes. The study’s findings support Braak's disease stage scheme and provide new insights into Parkinson’s progression.
Research found that voluntary wheel running increased dopamine signaling in motor areas of mice. This increase remained even after exercise ended. The study suggests BDNF may catalyze increased dopamine signaling.
Researchers at the University of Cambridge used ultra-high strength '7T' MRI scanners to measure changes in the brains of people with Parkinson's disease, PSP, or good health. The study found that damage to the locus coeruleus region correlates with severe cognitive symptoms and apathy.
A new study reveals that running increases dopamine release and brain-derived neurotrophic factor (BDNF) levels, leading to improved learning, memory, and motor skills. The findings provide insight into the long-term effects of exercise on the brain and may lead to new treatments for Parkinson's disease.
A new circuit model provides an explanation for how deep brain stimulation (DBS) relieves Parkinson's disease motor symptoms by interrupting a vicious cycle between the subthalamic nucleus and the striatum. The model suggests that DBS restores a balance with other rhythm frequencies, enabling better movement control.
Researchers have developed a process to convert non-neuronal cells into functioning neurons that can take up residence in the brain and restore capacities undermined by Parkinson's destruction of dopaminergic cells. In a proof-of-concept study, one group of experimentally engineered cells performs optimally in terms of survival, growth...
The authors of a Call to Action emphasize the value of incorporating patient perspectives in clinical Parkinson's disease studies and recommend how to include patient researchers effectively. Patient involvement can help design better studies, ensure tolerable protocols, and improve research outcomes. However, specific challenges must ...
A study reveals the DJ1 protein's role in Parkinson's disease by demonstrating its link to aberrant cell cycle re-entry, which leads to neuronal death. This finding could pave the way for new therapeutic approaches that prevent neuronal death and combat symptoms.
A new study suggests that supplementing a diet with Ascidiacea, also known as sea squirts, reverses some main signs of aging in animal models. The researchers found that plasmalogens, vital to body processes, decrease with age and contribute to neurodegenerative diseases like Alzheimer's and Parkinson's.
Researchers at the University of Cambridge have identified a new mechanism that appears to reverse the build-up of aggregates in neurodegenerative diseases, such as Alzheimer's and Parkinson's. By stressing cells, they found that protein misfolding was eliminated, potentially allowing for the refolding of correctly folded proteins.
Researchers found a correlation between Parkinson's gene alpha-synuclein and vocal production in zebra finches. The study suggests that this link could lead to earlier diagnoses and treatments for Parkinson's patients.
Research suggests dopamine is involved in emotion recognition, particularly in low-dose individuals. Dopamine levels influence emotional perception, with lower levels improving emotional recognition while higher levels impairing it. This finding has implications for understanding social cognition impairments in neurological disorders.
Researchers discovered a novel mutation in the alpha-synuclein gene that causes severe Lewy body pathology, revealing distinct mechanisms of neurodegeneration. The E83Q mutation influences alpha-synuclein's structure and aggregation properties, leading to increased pathology formation and toxicity.
UTHealth Houston's UTMOVE fellowship program has been chosen by The Michael J. Fox Foundation for Parkinson's Research to train a new generation of movement disorder specialists. The two-year program will provide fellows with comprehensive training in diagnosing and treating Parkinson's disease, as well as opportunities for research an...
Research shows that stable basal ganglia activity is essential for smooth movements, as disrupting this activity leads to unstable and involuntary movements. The study used a chemogenetic tool to suppress neural activity in the subthalamic nucleus of macaque monkeys, inducing abnormal movements.
A new deep learning method, PDD-Net, uses 3D deep convolutional neural networks to extract deep metabolic imaging indices from PET scans for differential diagnosis of parkinsonian diseases. The method achieved high sensitivity and specificity rates for Parkinson's disease and other parkinsonian syndromes.
A doctor's visit from the future describes patient care in 2042, where diagnosis and treatment are personalized based on individual biological abnormalities. Researchers believe this approach could lead to more effective treatments for neurodegenerative disorders.
Research reveals that an imbalance in gut microbiota, known as dysbiosis, may contribute to the development and progression of Parkinson's disease. Studies found a direct correlation between gut dysbiosis and Parkinson's, with certain bacteria contributing to protein aggregation and neuronal damage.
Researchers developed a new method of deep brain stimulation driven by motor cortical activity to treat Parkinson's disease. This approach, known as adaptive DBS (aDBS), uses γ2 band activity from the primary motor cortex to modulate stimulation parameters and reduce battery consumption.
Researchers at UCLA have discovered that amyloid fibrils in the brains of patients with frontotemporal degeneration are composed of the protein TMEM106B, not TDP-43 as expected. This finding may lead to new focus on TMEM106B in FTLD and similar brain diseases.
A new study from the University of Eastern Finland found that frontotemporal dementia patients with extrapyramidal symptoms have significant brainstem atrophy and reduced metabolism, facilitating differential diagnostics for FTD. This can help distinguish between FTD and other diseases causing extrapyramidal symptoms.